文献速递重症综合管理与镇静镇痛心脑血管急症

微生物组相关代谢物在创伤性脑损伤中的作用及其临床意义:范围综述

The Role of Microbiome-Associated Metabolites and Their Clinical Implications in Traumatic Brain Injury: A Scoping Review.
PubMed 文献 · Neurocrit Care · 2026-06-05
一句话结论临床前与临床数据提示,TBI后肠道菌群失调及短链脂肪酸、色氨酸代谢物、胆汁酸和多胺等代谢物改变可能影响继发性损伤与恢复,但监测与治疗性调控能否改善预后尚待转化研究确定。

该范围综述汇总了TBI特异性临床前与临床数据,探讨微生物组-肠-脑轴在创伤性脑损伤中的作用。TBI及神经重症监护措施(机械通气、镇静、饮食调整、抗生素)促进菌群失调和微生物代谢物产生改变。短链脂肪酸、色氨酸代谢物、胆汁酸和多胺等生物活性分子参与调节血脑屏障完整性、免疫激活、神经传递和能量代谢。新出现的证据提示这些代谢物水平改变可能影响继发性损伤级联并塑造恢复轨迹,但监测和治疗性调控微生物组-肠-脑轴能否改善患者恢复尚需转化研究确定。

要点

  • TBI及神经重症监护措施(机械通气、镇静、饮食调整、抗生素)促进菌群失调和微生物代谢物产生改变。
  • 短链脂肪酸、色氨酸代谢物、胆汁酸和多胺等代谢物参与调节血脑屏障完整性、免疫激活、神经传递和能量代谢。
  • 新出现的临床前与临床数据提示,TBI后这些代谢物水平改变可能影响继发性损伤级联并塑造恢复轨迹。
  • 了解这些通路可能为未来优化治疗提供信息,包括靶向微生物组调控、饮食干预或代谢物补充。
  • 监测和治疗性调控微生物组-肠-脑轴能否改善患者恢复轨迹尚待转化研究确定。

适用人群与场景

  • 创伤性脑损伤(TBI)患者,涵盖临床前模型与人类研究数据。

研究设计与关键结果

  • 本范围综述汇总了TBI特异性临床前与临床数据,涉及微生物组改变及微生物组相关代谢物信号传导,并将这些发现置于更广泛的微生物组-肠-脑研究背景中。
  • TBI和神经重症监护包括机械通气、镇静、饮食调整和抗生素促进菌群失调和微生物代谢物产生改变。
  • 短链脂肪酸、色氨酸代谢物、胆汁酸和多胺等生物活性分子在调节血脑屏障完整性、免疫激活、神经传递和能量代谢中起关键作用。
  • 新出现的临床前和临床数据提示,TBI后这些代谢物水平改变可能影响继发性损伤级联并塑造恢复。
  • 综述识别了关键知识空白,并概述了确定监测和治疗性调控微生物组-肠-脑轴能否增强患者恢复轨迹所需的转化研究优先事项。

证据类型、等级与局限

  • 证据类型:范围综述,汇总临床前与临床数据。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为,了解这些通路可能为未来优化治疗提供信息,包括靶向微生物组调控、饮食干预或代谢物补充。
  • 作者指出,监测和治疗性调控微生物组-肠-脑轴能否增强患者恢复轨迹尚待转化研究确定。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Traumatic brain injury (TBI) is a major public health challenge, with heterogeneous mechanisms and limited targeted therapies. Despite advances in neurocritical care, interventions to meaningfully alter long-term outcomes have been elusive, and treatment remains largely supportive. Parallel to this, increasing evidence from both preclinical models and human studies implicates the gut microbiome as a dynamic modulator of neurologic injury and recovery through the microbiome-gut-brain axis, a bidirectional network linking the central nervous system, gastrointestinal tract, and intestinal microbiota. TBI and neurointensive care including mechanical ventilation, sedation, dietary modification, and antibiotics contribute to the development of dysbiosis and altered production of microbial metabolites. These bioactive molecules, such as short-chain fatty acids, tryptophan metabolites, bile acids, and polyamines, play critical roles in regulating blood-barrier integrity, immune activation, neurotransmission, and energy metabolism. In TBI, emerging preclinical and clinical data suggest that altered levels of these metabolites may influence secondary injury cascades and shape recovery. In this review, we synthesize current TBI-specific preclinical and clinical data on microbiome alterations and microbiome-associated metabolite signaling following TBI, and we place these findings in the broader context of microbiome-gut-brain research. Understanding these pathways could inform future strategies to optimize treatment, including targeted microbiome modulation, dietary interventions, or metabolite supplementation. We identify key knowledge gaps and outline priorities for translational research needed to determine whether monitoring and therapeutic manipulation of the microbiome-gut-brain axis can enhance patients' recovery trajectory.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Dave AM, Chatrizeh M, Wolf MS, et al. The Role of Microbiome-Associated Metabolites and Their Clinical Implications in Traumatic Brain Injury: A Scoping Review. Neurocrit Care. 2026. PMID: 42249248. doi:10.1007/s12028-026-02562-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。